• Skip to main content

Clinical Study Connect

Plain-Language Clinical Study and Ingredient Research

  • Home
  • Research Guides
  • Ingredient Evidence
  • Study Design
  • Emerging Research
  • Safety
  • About

Berberine Benefits: What Human Studies Show, Doses and Safety

posted on October 5, 2026

Berberine is a compound found in plants such as goldenseal, barberry and Oregon grape. Pooled human trials point to modest improvements in blood sugar and inflammation markers, but many of those trials are small or low quality, and the weight-loss evidence is weak and mixed. It can cause stomach side effects and can interact with medicines, so it is a conversation for your clinician or pharmacist, not a stand-in for a prescription.

Quick facts

Topic What the research shows
Forms A substance found in goldenseal, barberry, Oregon grape and other plants, sold as a supplement. Some reviews pool trials of berberine and barberry together.
Doses used in studies They varied widely. In one review, weight effects showed up mainly at more than 1 gram per day. Another review found lower inflammation markers at doses under 1,000 mg per day.
Typical study length It varies. Weight effects were seen mainly in studies longer than 8 weeks. Inflammation findings came mainly from studies under 5 weeks.
Main studied uses Blood sugar and insulin resistance, inflammation markers, weight and BMI, blood lipids, gut bacteria, colorectal adenomas, and Helicobacter pylori infection.
Most common side effects Constipation, diarrhea, nausea, abdominal pain, bloating and gas.

What do human studies show?

Most of the evidence comes from meta-analyses, which pool many trials. If that term is new, see our guide to meta-analyses and systematic reviews. The strongest pattern is for blood sugar. Even there, the results are lab measures rather than outcomes you would feel, which is the issue our guide to surrogate outcomes explains.

Blood sugar and insulin resistance

A 2023 meta-analysis in the Journal of Nutrition pooled 20 randomized trials of berberine versus placebo (1,761 people). Berberine lowered fasting glucose by 0.52 mmol/L, HbA1c by 4.48 mmol/mol, fasting insulin by 2.36 mU/L, HOMA-IR (an insulin-resistance score) by 0.85, and 2-hour after-meal glucose by 1.81 mmol/L. The reductions looked larger in women, in people with diabetes and in Asian participants. The authors say these subgroup findings need replication, because the sex comparison rested on four studies in women and one in men.

A 2024 umbrella meta-analysis in Clinical Therapeutics, which pools earlier meta-analyses, also found lower fasting glucose, HbA1c, HOMA-IR and insulin in adults. Its authors note that earlier findings had been inconsistent.

Inflammation markers

A 2023 dose-response meta-analysis in Phytotherapy Research pooled 18 randomized trials (1,600 people) of berberine or barberry. It found lower IL-6 (-1.18 pg/mL), TNF-α (-3.72 pg/mL) and CRP (-1.33 mg/L). The authors flag low-quality studies and large differences between trials, and call for better research. The umbrella meta-analysis above reported similar directions for IL-6, TNF-α and CRP.

Weight and BMI

The evidence here is mixed. The National Center for Complementary and Integrative Health (NCCIH) describes a 2022 review of 18 studies on weight and 23 on BMI. It found significant decreases in both. Effects on weight appeared mainly with more than 1 gram per day for more than 8 weeks. NCCIH notes that many of those studies had a high risk of bias and inconsistent results. Most participants also had conditions such as diabetes or fatty liver disease, and most studies were done in Asian countries.

A Harvard Health Publishing answer by physician Toni Golen, MD, says there is no rigorous scientific evidence that berberine suppresses appetite or produces the weight loss of semaglutide drugs, and calls the “nature’s Ozempic” idea a social media claim. No study in this page’s sources shows berberine matching a prescription weight-loss drug, and it should not be treated as a substitute for one.

Other outcomes

A 2023 umbrella review in Phytotherapy Research examined 11 meta-analyses. It found berberine affected blood glucose, insulin resistance, blood lipids, body measures, inflammatory markers, colorectal adenomas and Helicobacter pylori infection compared with controls. Its authors also say the meta-analyses were of uneven quality and that high-quality trials are needed to confirm the effects.

A 2026 systematic review in Nutrients looked at gut bacteria. It covered seven randomized trials with 34 to 446 participants per arm, in people with type 2 diabetes, high blood lipids, colorectal adenoma, psychiatric disorders and Parkinson’s disease. Six of the seven found shifts in gut bacteria, along with improvements in glucose, lipids and inflammation markers. The authors say these shifts were not all favorable, that cause and effect is not established, and that the findings are hypothesis-generating.

For a general guide to weighing results like these, see evaluating evidence quality.

What doses did researchers use?

This describes what studies used and is not a recommendation. The studies differ a lot in amount and formulation, which NCCIH says makes the results hard to interpret. Two reported dose patterns:

  • Weight reductions appeared mainly in studies using more than 1 gram per day for more than 8 weeks (the review NCCIH describes).
  • Lower IL-6 and TNF-α appeared at doses under 1,000 mg per day and in studies shorter than 5 weeks (the 2023 inflammation meta-analysis).

These two findings come from different outcomes and different pooled studies, so they do not add up to a dose that works. The Journal of Nutrition review also compared trials by dose and duration, but its abstract does not give a result for them.

Is there a downside? Side effects and interactions

NCCIH says the side effects reported in studies are mainly gastrointestinal: nausea, abdominal pain, bloating, constipation or diarrhea. Harvard Health adds gas and upset stomach. The umbrella review also names constipation and diarrhea as the common ones, although it calls berberine a safe plant ingredient overall.

Medicine interactions. NCCIH says berberine may interact with medicines and has been shown to interact with cyclosporine, a transplant anti-rejection drug. Harvard Health says berberine can change how quickly the liver breaks down medications, including anti-clotting drugs and immunosuppressants, and so change how well they work. Harvard also notes that supplements are not regulated by the FDA, so there is no guarantee how much berberine a product contains.

Infants, pregnancy and breastfeeding. NCCIH says exposure to berberine has been linked to a harmful buildup of bilirubin in infants, which can cause brain damage. It considers berberine likely unsafe for infants and possibly unsafe in pregnancy or while breastfeeding.

Who should talk to a clinician first?

  • Anyone who takes prescription medicine, especially transplant drugs, anti-clotting drugs or other immunosuppressants. Both NCCIH and Harvard say to talk with your provider first. Do not change any medicine on your own.
  • Anyone who is pregnant, trying to become pregnant or breastfeeding, and anyone thinking of giving it to an infant.
  • Anyone with diabetes or blood sugar concerns. The studies measured blood sugar effects, so how it fits with your treatment is a question for the clinician who manages it.

What do doctors think?

The physician-written Harvard Health answer is cautious. It says to be skeptical of social media weight-loss claims and to talk to your doctor if you want to explore berberine. NCCIH, a US federal research agency, calls the weight-loss evidence not conclusive. The authors of the research reviews above generally say the blood sugar findings look promising but need high-quality confirmation.

Questions this page cannot settle for you

Several things people ask about are not answered by the NIH and Harvard pages or the reviews above:

  • Whether berberine lowers vitamin B12 or estrogen. The Journal of Nutrition authors note that berberine affects sex hormones, which is why they looked at sex differences in blood sugar results. That is not a finding about estrogen levels.
  • Which vitamins, including vitamin D, are fine to combine with it.
  • Whether morning or night is better.
  • Whether it can cause anxiety. The side effects reported in studies are mainly digestive.

For these, ask a pharmacist or your clinician, who can check against your full list of medicines and supplements. Bring the product label. If you want Mayo Clinic’s view, look at its own berberine page directly.

What is still unknown?

  • Whether benefits hold up in high-quality, large trials. Reviewers repeatedly cite low-quality studies and high variability between trials.
  • Whether results apply outside Asia. NCCIH notes very few studies were done in North America.
  • Whether results apply to healthy people. Most participants had diabetes, fatty liver disease or similar conditions.
  • Whether changes in gut bacteria cause the blood sugar changes.
  • Which dose and duration work best. Studies differed too much to say.

How do you read a label that lists berberine?

  • Amount. Look for berberine in milligrams per serving, then check how many servings a day the label directs. Compare that total with the study ranges above, remembering those are not recommendations.
  • Form. Some trials used berberine, and some pooled in barberry. A label listing a plant extract such as goldenseal, barberry or Oregon grape may not tell you how much berberine you are getting.
  • Proprietary blends. If berberine sits inside a blend listed only by total weight, you cannot tell how much of it is there and cannot compare it with study doses.
  • Content. Harvard Health says there is no guarantee how much berberine a supplement contains, so an unverified label amount is a claim. Our guide to ingredient evidence versus marketing claims shows how to separate the two.

Before you order

  • Ask your pharmacist whether berberine could interact with anything you take.
  • Check that the label gives the exact berberine amount and form.
  • Ask your clinician whether blood sugar results in studies apply to your situation.
  • Skip it if you are pregnant or breastfeeding, or if the person it is for is an infant, unless a clinician advises otherwise.

By ClinicalStudyConnect.com Research Desk

Clinical Study Connect

Plain-Language Clinical Study and Ingredient Research

Topics

  • Research Guides
  • Ingredient Evidence
  • Study Design
  • Emerging Research
  • Safety

Publication

  • Editorial Standards
  • Research Methodology
  • Contact

Policies

  • Medical Disclaimer
  • Privacy Policy
© 2026 Clinical Study ConnectFor information only, not medical advice. See our Medical Disclaimer.